tiprankstipranks
Trending News
More News >
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
Germany Market
Advertisement

Spago Nanomedical AB (7UX) Ratios

Compare
0 Followers

Spago Nanomedical AB Ratios

DE:7UX's free cash flow for Q1 2025 was kr-7.33. For the 2025 fiscal year, DE:7UX's free cash flow was decreased by kr and operating cash flow was kr-21.65. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.10 4.52 7.42 7.98 9.48
Quick Ratio
7.10 4.52 7.77 7.98 9.48
Cash Ratio
6.40 3.94 7.06 7.70 9.04
Solvency Ratio
-6.77 -3.59 -4.43 -5.68 -5.89
Operating Cash Flow Ratio
-7.36 -3.91 -4.34 -5.22 -5.97
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 24.79Mkr 40.24Mkr 56.45Mkr 47.58Mkr 26.69M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.18 1.28 1.04 1.04 1.02
Debt Service Coverage Ratio
-276.79 0.00 0.00 0.00 0.00
Interest Coverage Ratio
-291.14 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.81 1.07 1.60 1.36 1.53
Profitability Margins
Gross Profit Margin
-632.23%-1935.41%-1480.46%-2541.82%-121.64%
EBIT Margin
-1735.81%-3533.25%-3708.25%-5919.24%-5541.81%
EBITDA Margin
-1719.96%-3509.89%-3674.48%-5862.27%-5436.26%
Operating Profit Margin
-1809.06%-3533.25%-3744.31%-5938.18%-5544.44%
Pretax Profit Margin
-1694.63%-3509.81%-3718.88%-5919.85%-5534.50%
Net Profit Margin
-1694.58%-3509.81%-3729.51%-5920.45%-5527.19%
Continuous Operations Profit Margin
-1694.58%-3509.81%-3718.88%-5919.85%-5534.50%
Net Income Per EBT
100.00%100.00%100.29%100.01%99.87%
EBT Per EBIT
93.67%99.34%99.32%99.69%99.82%
Return on Assets (ROA)
-106.25%-79.69%-19.09%-20.39%-11.61%
Return on Equity (ROE)
6.07%-102.19%-19.94%-21.14%-11.84%
Return on Capital Employed (ROCE)
-131.45%-102.40%-20.02%-21.21%-11.88%
Return on Invested Capital (ROIC)
-131.45%-102.40%-20.07%-21.21%-11.86%
Return on Tangible Assets
-106.25%-79.69%-59.47%-70.45%-61.15%
Earnings Yield
-34.10%-65.89%-46.70%-9.73%-3.83%
Efficiency Ratios
Receivables Turnover
0.74 0.00 0.00 17.37 11.03
Payables Turnover
8.37 3.83 3.53 4.52 0.82
Inventory Turnover
0.00 0.00 -5.39 17.44M 758.00K
Fixed Asset Turnover
5.49 1.30 1.24 0.61 0.32
Asset Turnover
0.06 0.02 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
0.07 0.02 0.02 0.02 0.02
Cash Conversion Cycle
449.96 -95.27 -171.30 -59.79 -413.29
Days of Sales Outstanding
493.59 0.00 0.00 21.02 33.08
Days of Inventory Outstanding
0.00 0.00 -67.77 <0.01 <0.01
Days of Payables Outstanding
43.63 95.27 103.53 80.80 446.38
Operating Cycle
493.59 0.00 -67.77 21.02 33.09
Cash Flow Ratios
Operating Cash Flow Per Share
-0.09 -0.23 -0.29 -0.43 -0.32
Free Cash Flow Per Share
-0.09 -0.23 -0.31 -0.48 -0.43
CapEx Per Share
0.00 <0.01 0.03 0.06 0.11
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.10 1.13 1.34
Dividend Paid and CapEx Coverage Ratio
0.00 -293.52 -9.97 -7.69 -2.94
Capital Expenditure Coverage Ratio
0.00 -293.52 -9.97 -7.69 -2.94
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
-16.09 -37.33 -36.23 -53.89 -54.87
Free Cash Flow Yield
-32.38%-70.87%-49.91%-10.01%-5.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.93 -1.52 -2.14 -10.28 -26.12
Price-to-Sales (P/S) Ratio
49.69 53.26 79.87 608.42 1.44K
Price-to-Book (P/B) Ratio
3.69 1.55 0.43 2.17 3.09
Price-to-Free Cash Flow (P/FCF) Ratio
-3.09 -1.41 -2.00 -9.99 -19.64
Price-to-Operating Cash Flow Ratio
-3.09 -1.43 -2.20 -11.29 -26.32
Price-to-Earnings Growth (PEG) Ratio
-0.32 0.06 0.06 -0.24 0.94
Price-to-Fair Value
3.69 1.55 0.43 2.17 3.09
Enterprise Value Multiple
-2.08 -0.45 -0.57 -9.02 -25.03
Enterprise Value
67.78M 18.86M 22.08M 349.10M 465.38M
EV to EBITDA
-2.08 -0.45 -0.57 -9.02 -25.03
EV to Sales
35.69 15.68 20.95 528.94 1.36K
EV to Free Cash Flow
-2.22 -0.42 -0.53 -8.68 -18.50
EV to Operating Cash Flow
-2.22 -0.42 -0.58 -9.81 -24.80
Tangible Book Value Per Share
0.07 0.21 0.43 0.58 0.48
Shareholders’ Equity Per Share
0.07 0.21 1.48 2.21 2.75
Tax and Other Ratios
Effective Tax Rate
<0.01 0.00 >-0.01 >-0.01 <0.01
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
-0.09 -0.22 -0.29 -0.47 -0.33
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.98 0.99 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 16.22 28.50 9.76
SG&A to Revenue
0.00 0.00 7.66 11.43 15.24
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.26 1.06 0.97 0.91 0.99
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis